🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Multiple Myeloma, Refractory to Standard Treatment

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis NCT06971380Phase 21 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments NCT05137054Phase 142 sites📍 La Jolla📍 Atlanta📍 Indianapolis Regeneron Pharmaceuticals · Tests: Linvoseltamab, Daratumumab, Carfilzomib, Lenalidomide, Bortezomib A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) NCT07222761Phase 344 sites📍 Atlanta📍 New York📍 Columbus Regeneron Pharmaceuticals · Tests: Linvoseltamab, Carfilzomib, Daratumumab, Dexamethasone, Pomalidomide Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma NCT07772024Phase 31 site📍 Miami CellCentric Ltd. · Tests: InoPd, Investigator's choice of SAT A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) NCT06615479Phase 3141 sites📍 Birmingham📍 Los Angeles📍 Orange Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Tests: BMS-986393, Cyclophosphamide, Fludarabine, Daratumumab, Pomalidomide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy